Macrophages as key elements of Mixed-oxide [U-Pu(O2)] distribution and pulmonary damage after inhalation?

Anne Van der Meeren1, Agnes Moureau, Nina M Griffiths

  • 1Laboratoire de RadioToxicologie, CEA/DSV/iRCM, Bruyères le Châtel , Arpajon , France.

Abstract

Insights

Depleting alveolar macrophages (AM) in rats after mixed oxide (MOX) fuel inhalation increased lung actinide retention but did not significantly alter lung damage. Further research is needed to understand this inflammatory response.

Area of Science:

  • Environmental Science
  • Toxicology
  • Radiological Health

Background:

  • Alveolar macrophages (AM) play a crucial role in lung clearance of inhaled particles.
  • Mixed Oxide (MOX) fuel, containing uranium and plutonium oxides, poses inhalation risks.
  • Understanding AM function is vital for assessing lung damage from MOX exposure.

Purpose of the Study:

  • To investigate the impact of AM depletion on MOX distribution and clearance.
  • To evaluate lung damage and inflammatory responses following MOX inhalation after AM depletion.
  • To determine the effects on systemic actinide distribution.

Main Methods:

  • Rats were exposed to MOX via inhalation.
  • Alveolar macrophages were depleted using liposomal clodronate.
  • Lung changes, macrophage activation, and actinide distribution were monitored up to 3 months post-inhalation.

Main Results:

  • AM depletion led to increased lung and liver retention of alpha activity, with lower fecal and urinary excretion.
  • Foamy M2 macrophages accumulated MOX particles, correlating with lung fibrotic lesions and alveolitis.
  • Chemokine levels were elevated in AMs of MOX-exposed rats, irrespective of AM depletion.

Conclusions:

  • Transient AM depletion did not cause significant differences in lung damage post-MOX inhalation.
  • Increased lung actinide retention in depleted rats suggests a broader inflammatory response.
  • Further investigation is required to elucidate the mechanisms behind altered actinide retention.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.9K
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
26
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
29